A proprietary polyisobutylene rubber, which has been used in drug-eluting stents, is seeking to replace silicone in breast implants, enabling reconstructive prostheses that fight and treat cancer, reduce the risk of inflammation, and transmit painkillers. Judit Puskas, a chemical and biomolecular engineering professor of polymer science at the University of Akron’s Pepartment of Polymer Science, and her team have developed a proprietary polyisobutylene rubber that is said to superior barrier and mechanical properties compared to silicone rubber. Tagging Options Domain:  All Sites Issue Date:  PT – August 2013 Keywords:  breast implant drug eluting Judit Puskas polyisobutylene read more

See the original post:
Proprietary TPE could allow drug-eluting breast implants for cancer patients